CompletedPhase 2NCT01487954
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
Studying Toxic dermatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Comprehensive Cancer Center
- Principal Investigator
- Charles Kunos, MDCase Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
- Intervention
- alkaline water(dietary_supplement)
- Enrollment
- 45 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2010 – 2012
Study locations (1)
- University Hospitals-Westlake, Westlake, Ohio, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01487954 on ClinicalTrials.govOther trials for Toxic dermatosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07476807Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot StudySligo General Hospital
- RECRUITINGNANCT07524829Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer PatientsAzienda Sanitaria Locale di Asti
- RECRUITINGPHASE3NCT06044623Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer PatientsRegion Örebro County
- RECRUITINGNANCT04650256Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural SciencesUniversity of Miami
- ACTIVE NOT RECRUITINGPHASE2NCT04879563Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE ProjectRegion Örebro County